These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21083771

  • 1. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
    Elers J, Mørkeberg J, Jansen T, Belhage B, Backer V.
    Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
    [Abstract] [Full Text] [Related]

  • 2. Effect of salbutamol on neuromuscular function in endurance athletes.
    Decorte N, Bachasson D, Guinot M, Flore P, Levy P, Verges S, Wuyam B.
    Med Sci Sports Exerc; 2013 Oct; 45(10):1925-32. PubMed ID: 23559124
    [Abstract] [Full Text] [Related]

  • 3. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
    van Baak MA, de Hon OM, Hartgens F, Kuipers H.
    Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
    [Abstract] [Full Text] [Related]

  • 4. The effect of salbutamol on performance in elite nonasthmatic athletes.
    Meeuwisse WH, McKenzie DC, Hopkins SR, Road JD.
    Med Sci Sports Exerc; 1992 Oct; 24(10):1161-6. PubMed ID: 1435165
    [Abstract] [Full Text] [Related]

  • 5. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P.
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute salbutamol inhalation on quadriceps force and fatigability.
    Decorte N, Verges S, Flore P, Guinot M, Wuyam B.
    Med Sci Sports Exerc; 2008 Jul; 40(7):1220-7. PubMed ID: 18580400
    [Abstract] [Full Text] [Related]

  • 7. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B, Wuestenfeld JC, Kindermann W.
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
    Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V.
    Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
    [Abstract] [Full Text] [Related]

  • 9. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
    Dodd JD, Barry SC, Daly LE, Gallagher CG.
    J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
    [Abstract] [Full Text] [Related]

  • 10. The ergogenic effect of long-term use of high dose salbutamol.
    Dickinson J, Molphy J, Chester N, Loosemore M, Whyte G.
    Clin J Sport Med; 2014 Nov; 24(6):474-81. PubMed ID: 24451697
    [Abstract] [Full Text] [Related]

  • 11. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W.
    Sports Med; 2007 Nov; 37(2):95-102. PubMed ID: 17241101
    [Abstract] [Full Text] [Related]

  • 12. Effect of cold exposure (-15 degrees C) and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers.
    Sandsund M, Sue-Chu M, Helgerud J, Reinertsen RE, Bjermer L.
    Eur J Appl Physiol Occup Physiol; 1998 Mar; 77(4):297-304. PubMed ID: 9562357
    [Abstract] [Full Text] [Related]

  • 13. Effects of inhaled salbutamol in exercising non-asthmatic athletes.
    Goubault C, Perault MC, Leleu E, Bouquet S, Legros P, Vandel B, Denjean A.
    Thorax; 2001 Sep; 56(9):675-9. PubMed ID: 11514686
    [Abstract] [Full Text] [Related]

  • 14. Dose response of inhaled salbutamol on exercise performance and urine concentrations.
    Sporer BC, Sheel AW, McKenzie DC.
    Med Sci Sports Exerc; 2008 Jan; 40(1):149-57. PubMed ID: 18091010
    [Abstract] [Full Text] [Related]

  • 15. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction.
    Koch S, Karacabeyli D, Galts C, MacInnis MJ, Sporer BC, Koehle MS.
    J Sci Med Sport; 2015 Sep; 18(5):607-12. PubMed ID: 25156879
    [Abstract] [Full Text] [Related]

  • 16. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
    Pluim BM, de Hon O, Staal JB, Limpens J, Kuipers H, Overbeek SE, Zwinderman AH, Scholten RJ.
    Sports Med; 2011 Jan 01; 41(1):39-57. PubMed ID: 21142283
    [Abstract] [Full Text] [Related]

  • 17. Effects of an inhaled β2-agonist on cardiovascular function and sympathetic activity in healthy subjects.
    Snyder EM, Wong EC, Foxx-Lupo WT, Wheatley CM, Cassuto NA, Patanwala AE.
    Pharmacotherapy; 2011 Aug 01; 31(8):748-56. PubMed ID: 21923601
    [Abstract] [Full Text] [Related]

  • 18. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.
    Heir T, Stemshaug H.
    Scand J Med Sci Sports; 1995 Aug 01; 5(4):231-6. PubMed ID: 7552768
    [Abstract] [Full Text] [Related]

  • 19. Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists.
    Plomgaard AM, Schou AJ, Wolthers OD.
    Ann Hum Biol; 2006 Aug 01; 33(2):135-41. PubMed ID: 16684688
    [Abstract] [Full Text] [Related]

  • 20. Effects of β2-adrenergic stimulation on exercise capacity in normal subjects.
    Beloka SP, Janssen C, Woff E, Brassine E, Deboeck G, Randria J, Philippart de Foy V, van de Borne P, Naeije R.
    Eur J Appl Physiol; 2011 Sep 01; 111(9):2239-47. PubMed ID: 21327796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.